The effect of quinapril treatment on insulin resistance, leptin and high sensitive c-reactive protein in hypertensive patients

Clinical and Experimental Hypertension

Volumn 33, Issue 8, 2011, Pages 548-551

  Sari, Funda ^a   Eray, Esin ^a   Sari, Ramazan ^b  

^a MINISTRY OF HEALTH   (Turkey)

^b AKDENIZ UNIVERSITY   (Turkey)

Author keywords

angiotensin converting enzyme inhibitors; high sensitive C reactive protein; hypertension; insulin resistance; leptin

Indexed keywords

C REACTIVE PROTEIN; LEPTIN; QUINAPRIL;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BODY MASS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; C-REACTIVE PROTEIN; FEMALE; HOMEOSTASIS; HUMANS; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; LEPTIN; MALE; MIDDLE AGED; TETRAHYDROISOQUINOLINES; TREATMENT OUTCOME;

EID: 82455198891     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.3109/10641963.2011.577481     Document Type: Article

References (31)

1. Perticone F, Ceravolo R, Pujia A, et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 2001;104(2):191-196. (Pubitemid 32655837)
2. Lyon CJ, Law RE, Hsueh WA. Minireview: Adiposity, inflammation, and atherogenesis. Endocrinology 2003;144(6): 2195-2200.
3. Niskanen L, Laaksonen DE, Nyyssonen K, et al. Inflammation, abdominal obesity, and smoking as predictors of hypertension. Hypertension 2004;44(6):859-865. (Pubitemid 39577412)
4. Gonzalez AS, Guerrrero DB, Soto MB, et al. Metabolic syndrome, insulin resistance and the inflammation markers C-reactive protein and ferritin. Eur J Clin Nutr 2006;60(6): 802-809.
5. Reilly MP, Wolfe ML, Rhodes T, et al. Measures of insulin resistance and incremental value to the clinical diagnosis of metabolic syndrome in association with coronary atherosclerosis. Circulation 2004;110(7):803-809. (Pubitemid 39096007)
6. Fernandez-Real JM, Ricart W. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 2003;24(3):278-301. (Pubitemid 36724371)
7. Singhal A, Farooqi IS, Cole TJ, et al. Influence of leptin on arterial distensibility: A novel link between obesity and cardiovascular disease? Circulation 2002;8;106(15):1919-1924. (Pubitemid 35176295)
8. Shek EW, Brands MW, Hall JE. Chronic leptin infusion increases arterial pressure. Hypertension 1998;31(1 Pt 2): 409-414.
9. Rajagopalan S, Harrison DG. Reversing endothelial dysfunction with ACE inhibitors. A new trend. Circulation 1996;94(3):240-243. (Pubitemid 26266102)
10. Dagenais NJ, Jamali F. Protective effects of angiotensin II interruption: Evidence for antiinflammatory actions. Pharmacotherapy 2005;25(9):1213-1229. (Pubitemid 41244813)
11. Nakagawa H, Daihara M, Tamakawa H, et al. Effects of quinapril and losartan on insulin sensitivity in genetic hypertensive rats with different metabolic abnormalities. J Cardiovasc Pharmacol 1999;34(1):28-33. (Pubitemid 29296132)
12. Paolisso G, Gambardella A, Verza M, et al. ACE inhibition improves insulin-sensitivity in aged insulin-resistant hypertensive patients. J Hum Hypertens 1992;6(3): 175-179.
13. Umeda M, Kanda T, Murakami M. Effects of angiotensin II receptor antagonists on insulin resistance syndrome and leptin in sucrose-fed spontaneously hypertensive rats. Hypertens Res 2003;26(6):485-492. (Pubitemid 36849730)
14. Fogari R, Derosa G, Zoppi A, et al. Comparison of the effects of valsartan and felodipine on plasma leptin and insulin sensitivity in hypertensive obese patients. Hypertens Res 2005;28(3):209-214. (Pubitemid 40812604)
15. Fogari R, Zoppi A, Corradi L, et al. Comparative effects of lisinopril and losartan on insulin sensitivity in the treatment of non diabetic hypertensive patients. Br J Clin Pharmacol 1998;46(5):467-471. (Pubitemid 28484734)
16. Moan A, Hoieggen A, Nordby G, et al. Effects of losartan on insulin sensitivity in severe hypertension: connections through sympathetic nervous system activity? J Hum Hypertens 1995;9 suppl 5:S45-50.
17. Itoh K, Imai K, Masuda T, et al. Relationship between changes in serum leptin levels and blood pressure after weight loss. Hypertens Res 2002;25(6):881-886. (Pubitemid 36024644)
18. Koh KK, Quon MJ, Han SH, et al. Anti-inflammatory and metabolic effects of candesartan in hypertensive patients. Int J Cardiol 2006;22;108(1):96-100. (Pubitemid 43324913)
19. Folli F, Kahn CR, Hansen H, et al. Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk. J Clin Invest 1997;100(9): 2158-2169. (Pubitemid 27500137)
20. The Seventh Report of the National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 2003; 289:2560-2572.
21. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985;28:412-419. (Pubitemid 15018832)
22. Jastrzebski M, Czarnecka D, Rajzer M, Kawecka-Jaszcz K. Increased levels of inflammatory markers in hypertensives with target organ damage. Kardiol Pol 2006;64(8): 802-809. (Pubitemid 44510424)
23. Ren J. Leptin and hyperlentinemia-from friend to foe for cardiovascular function. J Endocrinol 2004;181(1):1-10. (Pubitemid 38584659)
24. Eikelis N, Schlaich M, Aggarwal A, et al. Interactions between leptin and the human sympathetic nervous system. Hypertension 2003;41(5):1072-1079. (Pubitemid 36548605)
25. Guha PK, Villarreal D, Reams GP, Freeman RH. Role of leptin in the regulation of body fluid volume and pressures. Am J Ther 2003;10(3):211-218.
26. Agata J, Masuda A, Takada M, et al. High plasma immunoreactive leptin level in essential hypertension. Am J Hypertens 1997;10(10 Pt 1):1171-1174. (Pubitemid 27486351)
27. Shek EW, Brands MW, Hall JE. Chronic leptin infusion increases arterial pressure. Hypertension 1998;31(1 Pt 2): 409-414.
28. Paolisso G, Tagliamonte MR, Galderisi M, et al. Plasma leptin concentration, insulin sensitivity, and 24-hour ambulatory blood pressure and left ventricular geometry. Am J Hypertens 2001;14(2):114-120. (Pubitemid 32171562)
29. Miatello R, Cruzado M, Risler N. Mechanisms of cardiovascular changes in an experimental model of syndrome X and pharmacological intervention on the renin-angiotensin-system. Curr Vasc Pharmacol 2004;2(4):371-377. (Pubitemid 39200187)
30. Barton M, Carmona R, Ortmann J, et al. Obesity-associated activation of angiotensin and endothelin in the cardiovascular system. Int J Biochem Cell Biol 2003;35(6):826-837. (Pubitemid 36379324)
31. Ailhaud G, Fukamizu A, Massiera F, et al. Angiotensinogen, angiotensin II and adipose tissue development. Int J Obes Relat Metab Disord 2000;24 suppl 4:S33-35.